About this trial
Remote robot-assisted laparoscopic surgery will be performed for gynecological surgical treatment through 5G network, while the safety and effectiveness will be studied.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who require endoscopic surgery
Voluntarily participate in this study and sign informed consent in writing
Disqualifiers
Patients with malignant tumors with clinical stage IV
Those who require emergency surgery
Presence of active bleeding, severe abnormal coagulopathy (prothrombin time (PT) or international normalized ratio (INR) greater than 1.5 times the upper limit of normal), or platelet count < 80×10^9/L
Patient has severe cardiovascular or circulatory disease and cannot tolerate surgery
Trial design
Single group
Treatments tested in this trial
Laparoscopic surgery
Procedure/SurgeryThe laparoscopic surgery system is applied to gynecology and 5G remote surgical treatment.
Treatment groups
Trial outcomes
Primary outcomes
surgical complications
The Satava classification system is used to evaluate intraoperative complications: Level Ⅰ: No impact on the patient, no treatment required or only conservative treatment is needed. Level Ⅱ: The mistake is immediately recognized and corrected, with no serious consequences. Level Ⅲ: The mistake is not recognized, leading to serious consequences. The Clavien-Dindo classification system is used to assess postoperative complications: Grade Ⅰ: Abnormal situations that do not require drug treatment or surgical, endoscopic, or radiologic intervention. Grade Ⅱ: Complications requiring drug treatment, but not requiring surgery, endoscopy, or radiologic intervention. Grade Ⅲ: Complications requiring surgical, endoscopic, or radiologic intervention, with Ⅲa not requiring general anesthesia and Ⅲb requiring general anesthesia. Grade Ⅳ: Life-threatening complications requiring ICU management, with Ⅳa for single-organ dysfunction and Ⅳb for multiple organ dysfunction. Grade Ⅴ: Death.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.